510(k) K260214

STA® - Liquid Anti-Xa by Diagnostica Stago, Inc. — Product Code KFF

K260214 is an FDA 510(k) premarket notification submitted by Diagnostica Stago, Inc. for the device "STA® - Liquid Anti-Xa". The FDA issued a decision of Substantially Equivalent on Sep 24, 2026. The device falls under product code KFF (Assay, Heparin), a Class II device regulated under 21 CFR 864.7525. Diagnostica Stago, Inc. has 21 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 24, 2026
Date Received
Jan 23, 2026
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Assay, Heparin
Device Class
Class II
Regulation Number
864.7525
Review Panel
HE
Submission Type
510(k)

Source: FDA 510(k) database entry for K260214. Report a data issue: hello@regdatalab.com.